Lin28a is a putative factor in regulating cancer stem cell-like properties in side population cells of oral squamous cell carcinoma

Experimental Cell Research

Volumn 319, Issue 8, 2013, Pages 1220-1228

  Hayashi, S ^a   Tanaka, J ^a   Okada, S ^a   Isobe, T ^a   Yamamoto, G ^a   Yasuhara, R ^a   Irie, T ^a   Akiyama, C ^a   Kohno, Y ^a   Tachikawa, T ^a   Mishima, K ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Cancer stem cells; Lin28a; Oral cancer; SP cells

Indexed keywords

LIN28A PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER STEM CELL; CELL INVASION; CELL POPULATION; CELL PROLIFERATION; COLONY FORMATION; DNA MICROARRAY; GENE; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUTH SQUAMOUS CELL CARCINOMA; PRIORITY JOURNAL; SIDE POPULATION CELL;

EID: 84876088428     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2013.03.004     Document Type: Article

References (45)

1. Gethins M. International Cancer Conference: targeted therapies boom expected in 3-5 years. J. Natl. Cancer Inst. 2011, 103:1491-1493.
2. Mishima K., Inoue K., Hayashi Y. Overexpression of extracellular-signal regulated kinases on oral squamous cell carcinoma. Oral Oncol. 2002, 38:468-474.
3. Mishima K., Yamada E., Masui K., Shimokawara T., Takayama K., Sugimura M., Ichijima K. Overexpression of the ERK/MAP kinases in oral squamous cell carcinoma. Mod. Pathol. 1998, 11:886-891.
4. Rodrigues V.C., Moss S.M., Tuomainen H. Oral cancer in the UK: to screen or not to screen. Oral Oncol. 1998, 34:454-465.
5. Yao M., Epstein J.B., Modi B.J., Pytynia K.B., Mundt A.J., Feldman L.E. Current surgical treatment of squamous cell carcinoma of the head and neck. Oral Oncol. 2007, 43:213-223.
6. Casiglia J., Woo S.B. A comprehensive review of oral cancer. Gen. Dent. 2001, 49:72-82.
7. Dick J.E. Stem cell concepts renew cancer research. Blood 2008, 112:4793-4807.
8. Dalerba P., Cho R.W., Clarke M.F. Cancer stem cells: models and concepts. Annu. Rev. Med. 2007, 58:267-284.
9. Visvader J.E., Lindeman G.J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat. Rev. Cancer 2008, 8:755-768.
10. Guan Y., Gerhard B., Hogge D.E. Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML). Blood 2003, 101:3142-3149.
11. Gupta P.B., Onder T.T., Jiang G., Tao K., Kuperwasser C., Weinberg R.A., Lander E.S. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 2009, 138:645-659.
12. Dean M., Fojo T., Bates S. Tumour stem cells and drug resistance. Nat. Rev. Cancer 2005, 5:275-284.
13. Rosen J.M., Jordan C.T. The increasing complexity of the cancer stem cell paradigm. Science 2009, 324:1670-1673.
14. Nguyen L.V., Vanner R., Dirks P., Eaves C.J. Cancer stem cells: an evolving concept. Nat. Rev. Cancer 2012, 12:133-143.
15. Singh S.K., Hawkins C., Clarke I.D., Squire J.A., Bayani J., Hide T., Henkelman R.M., Cusimano M.D., Dirks P.B. Identification of human brain tumour initiating cells. Nature 2004, 432:396-401.
16. Ricci-Vitiani L., Lombardi D.G., Pilozzi E., Biffoni M., Todaro M., Peschle C., De Maria R. Identification and expansion of human colon-cancer-initiating cells. Nature 2007, 445:111-115.
17. Clay M.R., Tabor M., Owen J.H., Carey T.E., Bradford C.R., Wolf G.T., Wicha M.S., Prince M.E. Single-marker identification of head and neck squamous cell carcinoma cancer stem cells with aldehyde dehydrogenase. Head Neck 2010, 32:1195-1201.
18. Chiou S.H., Yu C.C., Huang C.Y., Lin S.C., Liu C.J., Tsai T.H., Chou S.H., Chien C.S., Ku H.H., Lo J.F. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma. Clin. Cancer Res. 2008, 14:4085-4095.
19. Zhang P., Zhang Y., Mao L., Zhang Z., Chen W. Side population in oral squamous cell carcinoma possesses tumor stem cell phenotypes. Cancer Lett. 2009, 277:227-234.
20. Yanamoto S., Kawasaki G., Yamada S., Yoshitomi I., Kawano T., Yonezawa H., Rokutanda S., Naruse T., Umeda M. Isolation and characterization of cancer stem-like side population cells in human oral cancer cells. Oral Oncol. 2011, 47:855-860.
21. Michifuri Y., Hirohashi Y., Torigoe T., Miyazaki A., Kobayashi J., Sasaki T., Fujino J., Asanuma H., Tamura Y., Nakamori K., Hasegawa T., Hiratsuka H., Sato N. High expression of ALDH1 and SOX2 diffuse staining pattern of oral squamous cell carcinomas correlates to lymph node metastasis. Pathol. Int. 2012, 62:684-689.
22. Lee A., Kessler J.D., Read T.A., Kaiser C., Corbeil D., Huttner W.B., Johnson J.E., Wechsler-Reya R.J. Isolation of neural stem cells from the postnatal cerebellum. Nat. Neurosci. 2005, 8:723-729.
23. Chen S.F., Nieh S., Jao S.W., Liu C.L., Wu C.H., Chang Y.C., Yang C.Y., Lin Y.S. Quercetin suppresses drug-resistant spheres via the p38 MAPK-Hsp27 apoptotic pathway in oral cancer cells. PLoS One 2012, 7:e49275.
24. Goodell M.A., Brose K., Paradis G., Conner A.S., Mulligan R.C. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 1996, 183:1797-1806.
25. Golebiewska A., Brons N.H., Bjerkvig R., Niclou S.P. Critical appraisal of the side population assay in stem cell and cancer stem cell research. Cell Stem Cell 2011, 8:136-147.
26. Zhou S., Morris J.J., Barnes Y., Lan L., Schuetz J.D., Sorrentino B.P. Bcrp1 gene expression is required for normal numbers of side population stem cells in mice, and confers relative protection to mitoxantrone in hematopoietic cells in vivo. Proc. Natl. Acad. Sci. USA 2002, 99:12339-12344.
27. Allen J.D., Van Dort S.C., Buitelaar M., van Tellingen O., Schinkel A.H. Mouse breast cancer resistance protein (Bcrp1/Abcg2) mediates etoposide resistance and transport, but etoposide oral availability is limited primarily by P-glycoprotein. Cancer Res. 2003, 63:1339-1344.
28. Mishima K., Inoue H., Nishiyama T., Mabuchi Y., Amano Y., Ide F., Matsui M., Yamada H., Yamamoto G., Tanaka J., Yasuhara R., Sakurai T., Lee M.C., Chiba K., Sumimoto H., Kawakami Y., Matsuzaki Y., Tsubota K., Saito I. Transplantation of side population cells restores the function of damaged exocrine glands through clusterin. Stem Cells 2012, 30:1925-1937.
29. Moss E.G., Tang L. Conservation of the heterochronic regulator Lin-28, its developmental expression and microRNA complementary sites. Dev. Biol. 2003, 258:432-442.
30. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., Nie J., Jonsdottir G.A., Ruotti V., Stewart R., Slukvin I.I., Thomson J.A. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
31. Okita K., Nakagawa M., Hyenjong H., Ichisaka T., Yamanaka S. Generation of mouse induced pluripotent stem cells without viral vectors. Science 2008, 322:949-953.
32. Viswanathan S.R., Powers J.T., Einhorn W., Hoshida Y., Ng T.L., Toffanin S., O'Sullivan M., Lu J., Phillips L.A., Lockhart V.L., Shah S.P., Tanwar P.S., Mermel C.H., Beroukhim R., Azam M., Teixeira J., Meyerson M., Hughes T.P., Llovet J.M., Radich J., Mullighan C.G., Golub T.R., Sorensen P.H., Daley G.Q. Lin28 promotes transformation and is associated with advanced human malignancies. Nat. Genet. 2009, 41:843-848.
33. Zhou S., Schuetz J.D., Bunting K.D., Colapietro A.M., Sampath J., Morris J.J., Lagutina I., Grosveld G.C., Osawa M., Nakauchi H., Sorrentino B.P. The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype,. Nat. Med. 2001, 7:1028-1034.
34. Hirschmann-Jax C., Foster A.E., Wulf G.G., Nuchtern J.G., Jax T.W., Gobel U., Goodell M.A., Brenner M.K. A distinct side population of cells with high drug efflux capacity in human tumor cells. Proc. Natl. Acad. Sci. USA 2004, 101:14228-14233.
35. Kondo T., Setoguchi T., Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc. Natl. Acad. Sci. USA 2004, 101:781-786.
36. Chiba T., Kita K., Zheng Y.W., Yokosuka O., Saisho H., Iwama A., Nakauchi H., Taniguchi H. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology 2006, 44:240-251.
37. Thornton J.E., Chang H.M., Piskounova E., Gregory R.I. Lin28-mediated control of let-7 microRNA expression by alternative TUTases Zcchc11 (TUT4) and Zcchc6 (TUT7). RNA 2012, 18:1875-1885.
38. Puglisi M.A., Barba M., Corbi M., Errico M.F., Giorda E., Saulnier N., Boninsegna A., Piscaglia A.C., Carsetti R., Cittadini A., Gasbarrini A., Sgambato A. Identification of Endothelin-1 and NR4A2 as CD133-regulated genes in colon cancer cells. J. Pathol. 2011, 225:305-314.
39. Viswanathan S.R., Daley G.Q. Lin28: a microRNA regulator with a macro role. Cell 2010, 140:445-449.
40. Dangi-Garimella S., Yun J., Eves E.M., Newman M., Erkeland S.J., Hammond S.M., Minn A.J., Rosner M.R. Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7. EMBO J. 2009, 28:347-358.
41. Weidhaas J.B., Babar I., Nallur S.M., Trang P., Roush S., Boehm M., Gillespie E., Slack F.J. MicroRNAs as potential agents to alter resistance to cytotoxic anticancer therapy. Cancer Res. 2007, 67:11111-11116.
42. Sureshbabu A., Okajima H., Yamanaka D., Tonner E., Shastri S., Maycock J., Szymanowska M., Shand J., Takahashi S., Beattie J., Allan G., Flint D. IGFBP5 induces cell adhesion, increases cell survival and inhibits cell migration in MCF-7 human breast cancer cells. J. Cell. Sci. 2012, 125:1693-1705.
43. Miura N., Takemori N., Kikugawa T., Tanji N., Higashiyama S., Yokoyama M. Adseverin: a novel cisplatin-resistant marker in the human bladder cancer cell line HT1376 identified by quantitative proteomic analysis. Mol. Oncol. 2012, 6:311-322.
44. Zhang M., Ma Q., Hu H., Zhang D., Li J., Ma G., Bhat K., Wu E. Stem cell factor/c-kit signaling enhances invasion of pancreatic cancer cells via HIF-1alpha under normoxic condition. Cancer Lett. 2011, 303:108-117.
45. Kudo Y., Ogawa I., Kitajima S., Kitagawa M., Kawai H., Gaffney P.M., Miyauchi M., Takata T. Periostin promotes invasion and anchorage-independent growth in the metastatic process of head and neck cancer. Cancer Res. 2006, 66:6928-6935.